Actionable news
0
All posts from Actionable news
Actionable news in MRK: MERCK & CO. Inc,

Merck (MRK) Stock Upgraded at Credit Suisse

NEW YORK (TheStreet) -- Merck (MRK) stock was upgraded to "outperform" from "neutral" at Credit Suisse in a note released earlier today.

The firm hiked its price target on shares of the Kenilworth, NJ-based healthcare company to $73 from $62.

On Friday Bristol-Myers Squibb (BMY) announced that its Opdivo non-small cell lung cancer treatment missed its primary endpoint in a phase 3 trial. The Opdivo setback is viewed as a win for Merck's rival drug Keytruda.

STOCKS TO BUY: TheStreet Quant Ratings has...


More